Rocket Pharmaceuticals, Inc. logo

Rocket Pharmaceuticals, Inc.

NASDAQ:RCKT

Overview | Financials
Company Name Rocket Pharmaceuticals, Inc.
Symbol RCKT
Currency USD
Price 18.51
Market Cap 1,683,963,909
Dividend Yield 0%
52-week-range 15.27 - 32.525
Industry Biotechnology
Sector Healthcare
CEO Dr. Gaurav D. Shah M.D.
Website https://rocketpharma.com

An error occurred while fetching data.

About Rocket Pharmaceuticals, Inc.

Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells or

Related Stocks

The Oncology Institute, Inc. logo

The Oncology Institute, Inc.

TOI

0.3 USD

Evolus, Inc. logo

Evolus, Inc.

EOLS

14.71 USD

Codexis, Inc. logo

Codexis, Inc.

CDXS

2.74 USD

Nektar Therapeutics logo

Nektar Therapeutics

NKTR

1.12 USD

SIGA Technologies, Inc. logo

SIGA Technologies, Inc.

SIGA

7.71 USD

uniQure N.V. logo

uniQure N.V.

QURE

5.42 USD

Merus N.V. logo

Merus N.V.

MRUS

50 USD

Financials

Numbers are in millions USD

Numbers are in millions USD